Studies examining changes in hippocampal BDNF levels and neurogenesis during stressful environmental exposure, such as chronic SI, found that miRNAs that target BDNF could be potential therapeutic targets for the treatment of anxiety and depressive-like behaviors that are often seen in patients after stroke [46,47,48]. The gene discussed is BDNF; the disease is Anxiety.